abstract |
Disclosed are pharmaceutical compositions, particularly suitable for oral administration of sustained release oral pharmaceutical compositions, including heparin or derivatives thereof, in particular heparin having a different molecular weight for the treatment of inflammatory bowel disease and related diseases. |